共 359 条
[1]
Blobel CP(2005)ADAMs: key components in EGFR signalling and development Nat Rev Mol Cell Biol 6 32-43
[2]
Saftig P(2011)The “A Disintegrin And Metalloproteases” ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur J Cell Biol 90 527-535
[3]
Reiss K(2011)Alpha-secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential J Neurochem 116 10-21
[4]
Lichtenthaler SF(2009)The canonical Notch signaling pathway: unfolding the activation mechanism Cell 137 216-233
[5]
Kopan R(2009)Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling Mol Cell Biol 29 5679-5695
[6]
Ilagan MX(2009)Metalloprotease ADAM10 is required for Notch1 site 2 cleavage J Biol Chem 284 31018-31027
[7]
Bozkulak EC(2014)Regulated proteolysis of NOTCH2 and NOTCH3 receptors by ADAM10 and presenilins Mol Cell Biol 34 2822-2832
[8]
Weinmaster G(2002)The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts Hum Mol Genet 11 2615-2624
[9]
van Tetering G(2008)ADAM10 is essential for proteolytic activation of Notch during thymocyte development Int Immunol 20 1181-1187
[10]
van Diest P(2010)The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex J Neurosci 30 4833-4844